These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10357734)

  • 1. Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging.
    Engelson ES; Kotler DP; Tan Y; Agin D; Wang J; Pierson RN; Heymsfield SB
    Am J Clin Nutr; 1999 Jun; 69(6):1162-9. PubMed ID: 10357734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy.
    Brambilla P; Bricalli D; Sala N; Renzetti F; Manzoni P; Vanzulli A; Chiumello G; di Natale B; Viganò A
    AIDS; 2001 Dec; 15(18):2415-22. PubMed ID: 11740192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
    Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
    J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.
    Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J
    Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome.
    Kosmiski L; Kuritzkes D; Hamilton J; Sharp T; Lichtenstien K; Hill J; Eckel R
    HIV Med; 2003 Jul; 4(3):235-40. PubMed ID: 12859322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.
    Huang JS; Rietschel P; Hadigan CM; Rosenthal DI; Grinspoon S
    AIDS; 2001 May; 15(8):975-82. PubMed ID: 11399979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects.
    Scherzer R; Shen W; Bacchetti P; Kotler D; Lewis CE; Shlipak MG; Punyanitya M; Heymsfield SB; Grunfeld C;
    Am J Clin Nutr; 2008 Oct; 88(4):1088-96. PubMed ID: 18842798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Buffalo hump" in men with HIV-1 infection.
    Lo JC; Mulligan K; Tai VW; Algren H; Schambelan M
    Lancet; 1998 Mar; 351(9106):867-70. PubMed ID: 9525364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
    Maia BS; Engelson ES; Wang J; Kotler DP
    Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between hepatitis C virus coinfection and regional adipose tissue volume in HIV-infected men and women.
    Tien PC; Bacchetti P; Gripshover B; Overton ET; Rimland D; Kotler D;
    J Acquir Immune Defic Syndr; 2007 May; 45(1):60-5. PubMed ID: 17356466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women.
    McDermott AY; Shevitz A; Knox T; Roubenoff R; Kehayias J; Gorbach S
    Am J Clin Nutr; 2001 Nov; 74(5):679-86. PubMed ID: 11684538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.
    Kosmiski LA; Kuritzkes DR; Lichtenstein KA; Glueck DH; Gourley PJ; Stamm ER; Scherzinger AL; Eckel RH
    AIDS; 2001 Oct; 15(15):1993-2000. PubMed ID: 11600828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls.
    Delpierre C; Bonnet E; Marion-Latard F; Aquilina C; Obadia M; Marchou B; Massip P; Perret B; Bernard J
    J Clin Densitom; 2007; 10(4):376-80. PubMed ID: 17888698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women.
    Hadigan C; Miller K; Corcoran C; Anderson E; Basgoz N; Grinspoon S
    J Clin Endocrinol Metab; 1999 Jun; 84(6):1932-7. PubMed ID: 10372689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of polycystic ovary syndrome features in human immunodeficiency virus-infected women despite significant hyperinsulinemia and truncal adiposity.
    Johnsen S; Dolan SE; Fitch KV; Killilea KM; Shifren JL; Grinspoon SK
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5596-604. PubMed ID: 16076939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of body composition and fat distribution in HIV-infected and control subjects.
    Kotler DP; Rosenbaum K; Wang J; Pierson RN
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):228-37. PubMed ID: 10077170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass?
    Park YW; Heymsfield SB; Gallagher D
    Int J Obes Relat Metab Disord; 2002 Jul; 26(7):978-83. PubMed ID: 12080453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.